In accordance with the rules and regulations governing tenders and biddings in the People’s Republic of China (PRC), Department of Science and Technology of Guangdong Province (DSTGP) recently announced the results of the “2007 Guangdong Hong Kong Technology Cooperation Funding Scheme”. Solicitation of proposals under the scheme started on 17 September 2007 with vetting and assessment completed on 22 November 2007. The scheme was administered by DSTGP and jointly monitored by DSTGP and other related government agencies. Projects selected for funding under the theme of Biopharmaceutical and Modernization of Chinese Medicine are as follows:
Theme |
Project Title |
Organization |
Biopharmaceuticals and
natural medicines |
Commercialization development of Southeast Asia Type α-thalassemia reagent assay |
Zhuhai Special Economic Zone Haitai Biological Pharmaceutical Co., Ltd. |
Development of 13 types of high-risk Human Papilloma virus nucleic acid amplification (PCR) assay kit |
Chaozhou Kaipu Biological Instrument Co., Ltd. |
Commercialization development of a quantitative immunoassay for cancer based on angiopoietin-2 |
Guangdong Hong Ye Antibodies Technology Co. Ltd. |
Research and development of a recombinant human erythropoietin (rhEPO-Fc) injectable |
Dongguan Tai Li Biotech Co. Ltd. |
Clinical trials and product development of a new diabetic retinopathy drug “Tang Shi Ming Di Wan” (Category 5 Class II) |
Sun Yat-sen University |
R&D and commercialization development of a new Chinese Medicine for post-surgical adhesion in abdominal/pelvic area |
Guangdong An Fu Pharmaceutical Co., Ltd. |
Research & development of new Chinese Medicine, “Qing Du An Shen Capsule" |
Livzon Pharmaceutical Group Inc. |
Research and development of a botanical medicine “Luo Sai Tong Pills” |
Guangzhou Baiyunshan Hutchison Whampoa Traditional Chinese Medicine Co., Ltd. |
Clinical Study and commercialization of a huperzine A pad |
Guangzhou Xiangxue Pharmaceutical Co., Ltd. |
Modernization of Traditional Chinese Medicine |
Key precipitation technologies for liquid oral dosage forms |
Guangzhou Xing Qun Pharmaceutical Co. Ltd. |
Key technologies for enhancing the safety of Chinese medicine injectables |
Livzon Pharmaceutical Group Inc. |
Technology development for effective screening and structural modification of CM |
Sun Yat-sen University |
Development of traditional Chinese medicine capsules for the treatment of chronic diseases |
Guangzhou University of Chinese Medicine |
Development of traditional Chinese medicine injectables for treatment of cerebrovascular diseases |
Guangzhou Huacheng Pharmaceutical Co. |
